Bayer Aktiengesellschaft (ETR:BAYN) Trading Down 1.9% – Time to Sell?

Bayer Aktiengesellschaft (ETR:BAYN) shares traded down 1.9% during trading on Wednesday . The company traded as low as €36.88 and last traded at €37.74. 3,185,697 shares were traded during trading, The stock had previously closed at €38.47.

Bayer Aktiengesellschaft Trading Up 0.4%

The company has a quick ratio of 0.72, a current ratio of 1.00 and a debt-to-equity ratio of 144.30. The firm has a 50 day moving average price of €42.48 and a 200 day moving average price of €34.90. The stock has a market capitalization of $38.64 billion, a PE ratio of -43.91, a P/E/G ratio of 36.39 and a beta of 0.93.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.